xyralid hemorrhoidal
Generic: hemorrhoidal suppositories
Labeler: innovus pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
xyralid hemorrhoidal
Generic Name
hemorrhoidal suppositories
Labeler
innovus pharmaceuticals, inc.
Dosage Form
SUPPOSITORY
Routes
Active Ingredients
cocoa butter 88.5 g/100g, phenylephrine hydrochloride .26 g/100g
Manufacturer
Identifiers & Regulatory
Product NDC
57483-410
Product ID
57483-410_cd6eb255-a89d-40c5-90a0-13f907ab0ad5
Product Type
HUMAN OTC DRUG
Marketing Category
OTC MONOGRAPH FINAL
Application Number
part346
Listing Expiration
2026-12-31
Marketing Start
2018-03-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57483410
Hyphenated Format
57483-410
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
xyralid hemorrhoidal (source: ndc)
Generic Name
hemorrhoidal suppositories (source: ndc)
Application Number
part346 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 88.5 g/100g
- .26 g/100g
Packaging
- 4 BLISTER PACK in 1 CARTON (57483-410-13) / 24 g in 1 BLISTER PACK (57483-410-12)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["RECTAL"], "spl_id": "cd6eb255-a89d-40c5-90a0-13f907ab0ad5", "openfda": {"unii": ["512OYT1CRR", "04JA59TNSJ"], "rxcui": ["1438497"], "spl_set_id": ["8a885822-42e7-44e0-82d6-fa967123866e"], "manufacturer_name": ["Innovus Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 BLISTER PACK in 1 CARTON (57483-410-13) / 24 g in 1 BLISTER PACK (57483-410-12)", "package_ndc": "57483-410-13", "marketing_start_date": "20180325"}], "brand_name": "Xyralid Hemorrhoidal", "product_id": "57483-410_cd6eb255-a89d-40c5-90a0-13f907ab0ad5", "dosage_form": "SUPPOSITORY", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "57483-410", "generic_name": "Hemorrhoidal Suppositories", "labeler_name": "Innovus Pharmaceuticals, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Xyralid Hemorrhoidal", "active_ingredients": [{"name": "COCOA BUTTER", "strength": "88.5 g/100g"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": ".26 g/100g"}], "application_number": "part346", "marketing_category": "OTC MONOGRAPH FINAL", "marketing_start_date": "20180325", "listing_expiration_date": "20261231"}